Addrenex Pharmaceuticals Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $29M

Addrenex Pharmaceuticals General Information

Description

The company is currently operating in Stealth mode.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4825 Creekstone Drive
  • Suite 100
  • Durham, NC 27703
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • 4825 Creekstone Drive
  • Suite 100
  • Durham, NC 27703
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Addrenex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 13-Nov-2009 $29M Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Addrenex Pharmaceuticals’s complete valuation and funding history, request access »

Addrenex Pharmaceuticals Patents

Addrenex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2008261957-A1 Extended release formulation and method of treating adrenergic dysregulation Inactive 08-Jun-2007
CA-2689978-A1 Extended release formulation and method of treating adrenergic dysregulation Inactive 08-Jun-2007
EP-2155170-A2 Extended release formulation and method of treating adrenergic dysregulation Inactive 08-Jun-2007
WO-2008154339-A2 Extended release formulation and method of treating adrenergic dysregulation Inactive 08-Jun-2007
WO-2008154339-A3 Extended release formulation and method of treating adrenergic dysregulation Inactive 08-Jun-2007 A61K9/2018
To view Addrenex Pharmaceuticals’s complete patent history, request access »

Addrenex Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Solas BioVentures Venture Capital Minority
To view Addrenex Pharmaceuticals’s complete investors history, request access »

Addrenex Pharmaceuticals FAQs

  • When was Addrenex Pharmaceuticals founded?

    Addrenex Pharmaceuticals was founded in 2006.

  • Where is Addrenex Pharmaceuticals headquartered?

    Addrenex Pharmaceuticals is headquartered in Durham, NC.

  • What industry is Addrenex Pharmaceuticals in?

    Addrenex Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Addrenex Pharmaceuticals a private or public company?

    Addrenex Pharmaceuticals is a Private company.

  • What is the current valuation of Addrenex Pharmaceuticals?

    The current valuation of Addrenex Pharmaceuticals is .

  • What is Addrenex Pharmaceuticals’s current revenue?

    The current revenue for Addrenex Pharmaceuticals is .

  • Who are Addrenex Pharmaceuticals’s investors?

    Solas BioVentures has invested in Addrenex Pharmaceuticals.

  • When was Addrenex Pharmaceuticals acquired?

    Addrenex Pharmaceuticals was acquired on 13-Nov-2009.

  • Who acquired Addrenex Pharmaceuticals?

    Addrenex Pharmaceuticals was acquired by Sciele Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process